241 related articles for article (PubMed ID: 18829977)
1. Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis.
Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Benedetti A
Gut; 2009 Jul; 58(7):990-7. PubMed ID: 18829977
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
Marzioni M; Alpini G; Saccomanno S; Candelaresi C; Venter J; Rychlicki C; Fava G; Francis H; Trozzi L; Glaser S; Benedetti A
Gastroenterology; 2007 Jul; 133(1):244-55. PubMed ID: 17631146
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
4. Taurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.
Mancinelli R; Onori P; Gaudio E; Franchitto A; Carpino G; Ueno Y; Alvaro D; Annarale LP; Demorrow S; Francis H
Exp Biol Med (Maywood); 2009 Apr; 234(4):462-74. PubMed ID: 19234059
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
6. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.
Liu WJ; Jin HY; Lee KA; Xie SH; Baek HS; Park TS
Br J Pharmacol; 2011 Nov; 164(5):1410-20. PubMed ID: 21323903
[TBL] [Abstract][Full Text] [Related]
8. Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway.
Ueno Y; Francis H; Glaser S; Demorrow S; Venter J; Benedetti A; Fava G; Marzioni M; Alpini G
Exp Biol Med (Maywood); 2007 Jul; 232(7):942-9. PubMed ID: 17609511
[TBL] [Abstract][Full Text] [Related]
9. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism.
Marucci L; Alpini G; Glaser SS; Alvaro D; Benedetti A; Francis H; Phinizy JL; Marzioni M; Mauldin J; Venter J; Baumann B; Ugili L; LeSage G
Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G290-301. PubMed ID: 12388182
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis-induced arteriovenous fistula failure in chronic kidney disease.
Chien CT; Fan SC; Lin SC; Kuo CC; Yang CH; Yu TY; Lee SP; Cheng DY; Li PC
Thromb Haemost; 2014 Nov; 112(5):1051-64. PubMed ID: 25030617
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H
Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.
Li Y; Hansotia T; Yusta B; Ris F; Halban PA; Drucker DJ
J Biol Chem; 2003 Jan; 278(1):471-8. PubMed ID: 12409292
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
Yang H; Li H; Wang Z; Shi Y; Jiang G; Zeng F
J Surg Res; 2013 Dec; 185(2):825-32. PubMed ID: 23890403
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.
Younce CW; Burmeister MA; Ayala JE
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C508-18. PubMed ID: 23302777
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.
Nielsen LL; Young AA; Parkes DG
Regul Pept; 2004 Feb; 117(2):77-88. PubMed ID: 14700743
[TBL] [Abstract][Full Text] [Related]
16. Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts.
Marzioni M; Francis H; Benedetti A; Ueno Y; Fava G; Venter J; Reichenbach R; Mancino MG; Summers R; Alpini G; Glaser S
Am J Pathol; 2006 Feb; 168(2):398-409. PubMed ID: 16436655
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Himeno T; Kamiya H; Naruse K; Harada N; Ozaki N; Seino Y; Shibata T; Kondo M; Kato J; Okawa T; Fukami A; Hamada Y; Inagaki N; Seino Y; Drucker DJ; Oiso Y; Nakamura J
Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
[TBL] [Abstract][Full Text] [Related]
18. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor.
Montrose-Rafizadeh C; Yang H; Rodgers BD; Beday A; Pritchette LA; Eng J
J Biol Chem; 1997 Aug; 272(34):21201-6. PubMed ID: 9261127
[TBL] [Abstract][Full Text] [Related]
19. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
20. Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated mice.
Glaser S; Gaudio E; Renzi A; Mancinelli R; Ueno Y; Venter J; White M; Kopriva S; Chiasson V; DeMorrow S; Francis H; Meng F; Marzioni M; Franchitto A; Alvaro D; Supowit S; DiPette DJ; Onori P; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G297-305. PubMed ID: 21596993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
